Skip to Content
Merck
  • MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.

MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.

Cancer cell (2014-07-02)
Liling Wan, Xin Lu, Salina Yuan, Yong Wei, Feng Guo, Minhong Shen, Min Yuan, Rumela Chakrabarti, Yuling Hua, Heath A Smith, Mario Andres Blanco, Marina Chekmareva, Hao Wu, Roderick T Bronson, Bruce G Haffty, Yongna Xing, Yibin Kang
ABSTRACT

The Metadherin gene (MTDH) is prevalently amplified in breast cancer and associated with poor prognosis; however, its functional contribution to tumorigenesis is poorly understood. Using mouse models representing different subtypes of breast cancer, we demonstrated that MTDH plays a critical role in mammary tumorigenesis by regulating oncogene-induced expansion and activities of tumor-initiating cells (TICs), whereas it is largely dispensable for normal development. Mechanistically, MTDH supports the survival of mammary epithelial cells under oncogenic/stress conditions by interacting with and stabilizing Staphylococcal nuclease domain-containing 1 (SND1). Silencing MTDH or SND1 individually or disrupting their interaction compromises tumorigenenic potential of TICs in vivo. This functional significance of MTDH-SND1 interaction is further supported by clinical analysis of human breast cancer samples.

MATERIALS
Product Number
Brand
Product Description

Medroxyprogesterone acetate for system suitability, European Pharmacopoeia (EP) Reference Standard
Medroxyprogesterone acetate for peak identification, European Pharmacopoeia (EP) Reference Standard
USP
Medroxyprogesterone acetate, United States Pharmacopeia (USP) Reference Standard
Medroxyprogesterone acetate, European Pharmacopoeia (EP) Reference Standard
Supelco
Medroxyprogesterone 17-acetate, VETRANAL®, analytical standard
Sigma-Aldrich
Medroxyprogesterone 17-acetate, ≥97% (HPLC)